China Pharma Holdings (CPHI) Asset Utilization Ratio (2011 - 2026)
China Pharma Holdings (CPHI) reported Asset Utilization Ratio of 0.1 for Q1 2026, down 64.48% on a YoY basis from 0.3 in Q1 2025, and down 40.8% quarter-over-quarter from 0.18 in Q4 2025.
China Pharma Holdings (CPHI) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
China Pharma Holdings has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.1 in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio fell 64.48% year-over-year to 0.1; the trailing twelve-month figure through Mar 2026 stood at 0.1 (down 64.48% YoY), and the FY2025 full-year result was 0.18, down 37.47% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.1, down from 0.18 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.5 in Q3 2023, with the low at 0.1 in Q1 2026.
- Historically, Asset Utilization Ratio has averaged 0.37 across 5 years, with a median of 0.41 in 2022.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio grew 18.36% — and 2026, when it tumbled 64.48%.
- China Pharma Holdings' Asset Utilization Ratio stood at 0.48 in 2022, then fell by 7.6% to 0.44 in 2023, then declined by 27.5% to 0.32 in 2024, then plunged by 44.57% to 0.18 in 2025, then slumped by 40.8% to 0.1 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.1 (Q1 2026), 0.18 (Q4 2025), and 0.27 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.43 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.62 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.43 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.48 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 0.65 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.37 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.36 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.07 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.68 |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 | 0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.10 |
| Dec 31, 2025 | 0.18 |
| Sep 30, 2025 | 0.27 |
| Jun 30, 2025 | 0.31 |
| Mar 31, 2025 | 0.30 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | 0.39 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.50 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.48 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.47 |
| Jun 30, 2022 | 0.42 |
| Mar 31, 2022 | 0.41 |
| Dec 31, 2021 | 0.47 |
| Sep 30, 2021 | 0.51 |
| Jun 30, 2021 | 0.51 |